COVID-19 and senior care will be topic of March 25 webinar
Mar 18, 2020
Learn evidence-based ways to protect residents from serious harm that can come from the novel coronavirus at a free webinar on Wednesday, March 25.
Researchers: Drop 13% body weight to drop type 2 diabetes risk by 40%
By
Kimberly Marselas
Sep 10, 2020
An average loss of 13% of total body weight reduces the risk of developing type 2 diabetes by around 40% in obese individuals, researchers told the European and International Congress on Obesity.
Feds stepping up efforts to make coronavirus tests available
By
Alicia Lasek
Mar 09, 2020
Millions of COVID-19 diagnostic tests will become available this week, according to the White House and federal health agencies.
Free LTC infection prevention tool from Yale aims to help nursing home staff save time
By
Alicia Lasek
Nov 09, 2021
A one-stop set of infection prevention resources is meant to make work a bit easier for direct care providers, administrators, managers and support staff, say the Yale School of Nursing and the New York...
Team approach helps hospital cut antibiotic use in sepsis case study
By
Alicia Lasek
Jun 28, 2019
A team approach to antimicrobial stewardship resulted in decreased broad spectrum antibiotic use, reduced patient length of stay and cost reductions for a Pennsylvania hospital.
Alzheimer’s blood test to be used in memory-loss prevention trial
By
Alicia Lasek
Nov 12, 2021
The PrecivityAD blood test will lower barriers to participation in a new clinical trial that aims to prevent the symptoms of Alzheimer’s disease, researchers say.
Healthcare workers first in line for newly approved at-home coronavirus test
By
Alicia Lasek
Apr 21, 2020
Care providers are asked to complete a short eligibility assessment before ordering the FDA-authorized test kit. Self-swabs are mailed back for testing.
FDA advisers object to Alzheimer’s drug aducanumab ahead of final decision
By
Alicia Lasek
Apr 05, 2021
The experimental Alzheimer’s drug aducanumab is not ready for federal approval in June, advisers to the Food and Drug Administration say in a new JAMA editorial.
After 20 years on the market, AbbVie’s dry-eye drug Restasis to be available as generic
By
Alicia Lasek
Feb 03, 2022
Dry eyes affect nearly 19% percent of adults aged 75 years and older, according to data from a national survey.
Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...